nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Glyburide—gestational diabetes	0.36	0.402	CbGbCtD
Clomipramine—CYP2C19—Glyburide—gestational diabetes	0.233	0.261	CbGbCtD
Clomipramine—ABCB1—Glyburide—gestational diabetes	0.188	0.211	CbGbCtD
Clomipramine—CYP3A4—Glyburide—gestational diabetes	0.113	0.126	CbGbCtD
Clomipramine—Inappropriate antidiuretic hormone secretion—Glyburide—gestational diabetes	0.00541	0.0752	CcSEcCtD
Clomipramine—Encephalopathy—Glyburide—gestational diabetes	0.0049	0.0681	CcSEcCtD
Clomipramine—GSTP1—Glutathione conjugation—GGCT—gestational diabetes	0.00276	0.18	CbGpPWpGaD
Clomipramine—Deafness—Glyburide—gestational diabetes	0.00255	0.0355	CcSEcCtD
Clomipramine—Vascular purpura—Glyburide—gestational diabetes	0.00255	0.0355	CcSEcCtD
Clomipramine—Purpura—Glyburide—gestational diabetes	0.00237	0.0329	CcSEcCtD
Clomipramine—Diplopia—Glyburide—gestational diabetes	0.00228	0.0317	CcSEcCtD
Clomipramine—Eosinophilia—Glyburide—gestational diabetes	0.00195	0.0271	CcSEcCtD
Clomipramine—Sweating increased—Glyburide—gestational diabetes	0.00192	0.0267	CcSEcCtD
Clomipramine—Pancytopenia—Glyburide—gestational diabetes	0.00187	0.026	CcSEcCtD
Clomipramine—Photosensitivity reaction—Glyburide—gestational diabetes	0.0018	0.025	CcSEcCtD
Clomipramine—Jaundice—Glyburide—gestational diabetes	0.00171	0.0238	CcSEcCtD
Clomipramine—Agranulocytosis—Glyburide—gestational diabetes	0.00164	0.0228	CcSEcCtD
Clomipramine—Hepatitis—Glyburide—gestational diabetes	0.00158	0.0219	CcSEcCtD
Clomipramine—Visual impairment—Glyburide—gestational diabetes	0.00152	0.0211	CcSEcCtD
Clomipramine—Eye disorder—Glyburide—gestational diabetes	0.00147	0.0205	CcSEcCtD
Clomipramine—GSTP1—islet of Langerhans—gestational diabetes	0.00147	0.0758	CbGeAlD
Clomipramine—GSTP1—embryo—gestational diabetes	0.00143	0.0733	CbGeAlD
Clomipramine—Alopecia—Glyburide—gestational diabetes	0.00139	0.0194	CcSEcCtD
Clomipramine—Malnutrition—Glyburide—gestational diabetes	0.00137	0.0191	CcSEcCtD
Clomipramine—Vision blurred—Glyburide—gestational diabetes	0.00129	0.018	CcSEcCtD
Clomipramine—Tremor—Glyburide—gestational diabetes	0.00129	0.0179	CcSEcCtD
Clomipramine—Anaemia—Glyburide—gestational diabetes	0.00127	0.0177	CcSEcCtD
Clomipramine—Leukopenia—Glyburide—gestational diabetes	0.00123	0.0171	CcSEcCtD
Clomipramine—GSTP1—Phase II conjugation—GGCT—gestational diabetes	0.00123	0.0801	CbGpPWpGaD
Clomipramine—Convulsion—Glyburide—gestational diabetes	0.00119	0.0166	CcSEcCtD
Clomipramine—Myalgia—Glyburide—gestational diabetes	0.00117	0.0163	CcSEcCtD
Clomipramine—Arthralgia—Glyburide—gestational diabetes	0.00117	0.0163	CcSEcCtD
Clomipramine—Confusional state—Glyburide—gestational diabetes	0.00113	0.0157	CcSEcCtD
Clomipramine—Oedema—Glyburide—gestational diabetes	0.00112	0.0156	CcSEcCtD
Clomipramine—Shock—Glyburide—gestational diabetes	0.0011	0.0153	CcSEcCtD
Clomipramine—Nervous system disorder—Glyburide—gestational diabetes	0.0011	0.0153	CcSEcCtD
Clomipramine—Thrombocytopenia—Glyburide—gestational diabetes	0.0011	0.0153	CcSEcCtD
Clomipramine—HTR6—head—gestational diabetes	0.0011	0.0564	CbGeAlD
Clomipramine—Hyperhidrosis—Glyburide—gestational diabetes	0.00108	0.0151	CcSEcCtD
Clomipramine—Anorexia—Glyburide—gestational diabetes	0.00107	0.0149	CcSEcCtD
Clomipramine—Hypotension—Glyburide—gestational diabetes	0.00105	0.0146	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00102	0.0142	CcSEcCtD
Clomipramine—Paraesthesia—Glyburide—gestational diabetes	0.00101	0.014	CcSEcCtD
Clomipramine—HRH2—head—gestational diabetes	0.001	0.0516	CbGeAlD
Clomipramine—Dyspnoea—Glyburide—gestational diabetes	0.001	0.0139	CcSEcCtD
Clomipramine—Dyspepsia—Glyburide—gestational diabetes	0.000987	0.0137	CcSEcCtD
Clomipramine—Decreased appetite—Glyburide—gestational diabetes	0.000975	0.0136	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000968	0.0135	CcSEcCtD
Clomipramine—GSTP1—uterus—gestational diabetes	0.000961	0.0495	CbGeAlD
Clomipramine—GSTP1—adipose tissue—gestational diabetes	0.00094	0.0484	CbGeAlD
Clomipramine—Feeling abnormal—Glyburide—gestational diabetes	0.000924	0.0128	CcSEcCtD
Clomipramine—Gastrointestinal pain—Glyburide—gestational diabetes	0.000917	0.0127	CcSEcCtD
Clomipramine—Urticaria—Glyburide—gestational diabetes	0.000891	0.0124	CcSEcCtD
Clomipramine—Abdominal pain—Glyburide—gestational diabetes	0.000886	0.0123	CcSEcCtD
Clomipramine—Hypersensitivity—Glyburide—gestational diabetes	0.000826	0.0115	CcSEcCtD
Clomipramine—Asthenia—Glyburide—gestational diabetes	0.000804	0.0112	CcSEcCtD
Clomipramine—Pruritus—Glyburide—gestational diabetes	0.000793	0.011	CcSEcCtD
Clomipramine—HTR2B—uterus—gestational diabetes	0.000793	0.0408	CbGeAlD
Clomipramine—GSTP1—vagina—gestational diabetes	0.000781	0.0402	CbGeAlD
Clomipramine—HTR2B—adipose tissue—gestational diabetes	0.000775	0.0399	CbGeAlD
Clomipramine—Diarrhoea—Glyburide—gestational diabetes	0.000767	0.0107	CcSEcCtD
Clomipramine—ADRA2A—islet of Langerhans—gestational diabetes	0.000763	0.0393	CbGeAlD
Clomipramine—GSTP1—head—gestational diabetes	0.000722	0.0371	CbGeAlD
Clomipramine—GSTP1—Biological oxidations—GGCT—gestational diabetes	0.000718	0.0469	CbGpPWpGaD
Clomipramine—Vomiting—Glyburide—gestational diabetes	0.000713	0.00991	CcSEcCtD
Clomipramine—Rash—Glyburide—gestational diabetes	0.000707	0.00983	CcSEcCtD
Clomipramine—Dermatitis—Glyburide—gestational diabetes	0.000706	0.00982	CcSEcCtD
Clomipramine—Headache—Glyburide—gestational diabetes	0.000702	0.00977	CcSEcCtD
Clomipramine—Nausea—Glyburide—gestational diabetes	0.000666	0.00926	CcSEcCtD
Clomipramine—HTR2B—vagina—gestational diabetes	0.000644	0.0332	CbGeAlD
Clomipramine—HTR2C—head—gestational diabetes	0.000634	0.0326	CbGeAlD
Clomipramine—HTR2A—embryo—gestational diabetes	0.000628	0.0323	CbGeAlD
Clomipramine—SLC6A4—head—gestational diabetes	0.000601	0.0309	CbGeAlD
Clomipramine—HTR2B—head—gestational diabetes	0.000595	0.0306	CbGeAlD
Clomipramine—CYP2C19—vagina—gestational diabetes	0.000539	0.0277	CbGeAlD
Clomipramine—SLC6A2—head—gestational diabetes	0.000529	0.0272	CbGeAlD
Clomipramine—ADRA2A—uterus—gestational diabetes	0.000498	0.0256	CbGeAlD
Clomipramine—ADRA2A—adipose tissue—gestational diabetes	0.000487	0.0251	CbGeAlD
Clomipramine—ABCB1—islet of Langerhans—gestational diabetes	0.000425	0.0219	CbGeAlD
Clomipramine—ABCB1—embryo—gestational diabetes	0.000411	0.0212	CbGeAlD
Clomipramine—ADRA2A—vagina—gestational diabetes	0.000405	0.0208	CbGeAlD
Clomipramine—ADRA2A—head—gestational diabetes	0.000374	0.0192	CbGeAlD
Clomipramine—HTR2A—vagina—gestational diabetes	0.000344	0.0177	CbGeAlD
Clomipramine—HTR2A—head—gestational diabetes	0.000318	0.0164	CbGeAlD
Clomipramine—CYP2D6—head—gestational diabetes	0.00029	0.0149	CbGeAlD
Clomipramine—ABCB1—uterus—gestational diabetes	0.000277	0.0143	CbGeAlD
Clomipramine—ABCB1—adipose tissue—gestational diabetes	0.000271	0.014	CbGeAlD
Clomipramine—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.000267	0.0174	CbGpPWpGaD
Clomipramine—GSTP1—Biological oxidations—CYP19A1—gestational diabetes	0.00025	0.0163	CbGpPWpGaD
Clomipramine—GSTP1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000246	0.0161	CbGpPWpGaD
Clomipramine—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000226	0.0147	CbGpPWpGaD
Clomipramine—ABCB1—vagina—gestational diabetes	0.000225	0.0116	CbGeAlD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000225	0.0147	CbGpPWpGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000212	0.0139	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000211	0.0138	CbGpPWpGaD
Clomipramine—ABCB1—head—gestational diabetes	0.000208	0.0107	CbGeAlD
Clomipramine—SLC6A4—Monoamine Transport—TNF—gestational diabetes	0.000189	0.0123	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—NAMPT—gestational diabetes	0.000185	0.0121	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000182	0.0119	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000169	0.0111	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000169	0.0111	CbGpPWpGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000163	0.0106	CbGpPWpGaD
Clomipramine—SLC6A2—Monoamine Transport—TNF—gestational diabetes	0.000162	0.0106	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—AR—gestational diabetes	0.00016	0.0104	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000156	0.0102	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000151	0.00986	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000149	0.0097	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000139	0.00911	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000138	0.00904	CbGpPWpGaD
Clomipramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000137	0.00894	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000135	0.00883	CbGpPWpGaD
Clomipramine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000135	0.00882	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000132	0.00862	CbGpPWpGaD
Clomipramine—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000132	0.00861	CbGpPWpGaD
Clomipramine—SLC6A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000128	0.00838	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000127	0.00831	CbGpPWpGaD
Clomipramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000126	0.00822	CbGpPWpGaD
Clomipramine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000124	0.00811	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—GGCT—gestational diabetes	0.000123	0.00802	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00012	0.00783	CbGpPWpGaD
Clomipramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000111	0.00724	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—GLS2—gestational diabetes	0.000107	0.00701	CbGpPWpGaD
Clomipramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000107	0.00696	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—MTNR1B—gestational diabetes	0.000106	0.00693	CbGpPWpGaD
Clomipramine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000105	0.00687	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000104	0.0068	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000103	0.00671	CbGpPWpGaD
Clomipramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000102	0.00666	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000102	0.00666	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000102	0.00665	CbGpPWpGaD
Clomipramine—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000102	0.00665	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—MTNR1B—gestational diabetes	9.69e-05	0.00633	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—AR—gestational diabetes	9.62e-05	0.00628	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	9.47e-05	0.00618	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—LEP—gestational diabetes	9.38e-05	0.00613	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	8.92e-05	0.00582	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	8.66e-05	0.00565	CbGpPWpGaD
Clomipramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	8.64e-05	0.00564	CbGpPWpGaD
Clomipramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	8.23e-05	0.00537	CbGpPWpGaD
Clomipramine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	8.12e-05	0.0053	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	8.11e-05	0.0053	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—MTNR1B—gestational diabetes	7.82e-05	0.00511	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—MTNR1B—gestational diabetes	7.82e-05	0.00511	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—MTNR1B—gestational diabetes	7.11e-05	0.00464	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—MTNR1B—gestational diabetes	6.79e-05	0.00443	CbGpPWpGaD
Clomipramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	6.67e-05	0.00436	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—GCK—gestational diabetes	6.52e-05	0.00426	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	6.45e-05	0.00421	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—MTNR1B—gestational diabetes	6.18e-05	0.00403	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—MTNR1B—gestational diabetes	6e-05	0.00392	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	5.89e-05	0.00385	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—NAMPT—gestational diabetes	5.88e-05	0.00384	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—GCK—gestational diabetes	5.84e-05	0.00381	CbGpPWpGaD
Clomipramine—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	5.81e-05	0.0038	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	5.62e-05	0.00367	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—MTNR1B—gestational diabetes	5.48e-05	0.00358	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MTNR1B—gestational diabetes	5.45e-05	0.00356	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	5.42e-05	0.00354	CbGpPWpGaD
Clomipramine—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	5.35e-05	0.00349	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—TNF—gestational diabetes	5.32e-05	0.00347	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LEPR—gestational diabetes	5.31e-05	0.00347	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	5.15e-05	0.00336	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MTNR1B—gestational diabetes	4.97e-05	0.00325	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	4.59e-05	0.003	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—TNF—gestational diabetes	4.57e-05	0.00299	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	4.53e-05	0.00296	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—MTNR1B—gestational diabetes	4.42e-05	0.00289	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CYP19A1—gestational diabetes	4.27e-05	0.00279	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	4.27e-05	0.00279	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	4.27e-05	0.00279	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MTNR1B—gestational diabetes	4.2e-05	0.00274	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RBP4—gestational diabetes	4.09e-05	0.00267	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GGCT—gestational diabetes	4.09e-05	0.00267	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LEPR—gestational diabetes	4.07e-05	0.00266	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MTNR1B—gestational diabetes	4.01e-05	0.00262	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—MTNR1B—gestational diabetes	3.84e-05	0.00251	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEPR—gestational diabetes	3.72e-05	0.00243	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	3.63e-05	0.00237	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GLS2—gestational diabetes	3.57e-05	0.00233	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	3.54e-05	0.00231	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	3.5e-05	0.00228	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—MTNR1B—gestational diabetes	3.49e-05	0.00228	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MTNR1B—gestational diabetes	3.48e-05	0.00228	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—TNF—gestational diabetes	3.47e-05	0.00227	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	3.28e-05	0.00214	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GGCT—gestational diabetes	3.23e-05	0.00211	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MTNR1B—gestational diabetes	3.22e-05	0.0021	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—TNF—gestational diabetes	3.2e-05	0.00209	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MTNR1B—gestational diabetes	3.17e-05	0.00207	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RBP4—gestational diabetes	3.14e-05	0.00205	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEPR—gestational diabetes	3e-05	0.00196	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MTNR1B—gestational diabetes	2.94e-05	0.00192	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GGCT—gestational diabetes	2.9e-05	0.00189	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	2.87e-05	0.00188	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RBP4—gestational diabetes	2.86e-05	0.00187	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GGCT—gestational diabetes	2.83e-05	0.00185	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GLS2—gestational diabetes	2.82e-05	0.00184	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	2.81e-05	0.00184	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GGCT—gestational diabetes	2.66e-05	0.00174	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEPR—gestational diabetes	2.6e-05	0.0017	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GLS2—gestational diabetes	2.53e-05	0.00165	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.52e-05	0.00165	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GLS2—gestational diabetes	2.47e-05	0.00161	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MTNR1B—gestational diabetes	2.37e-05	0.00155	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEPR—gestational diabetes	2.37e-05	0.00155	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GLS2—gestational diabetes	2.33e-05	0.00152	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RBP4—gestational diabetes	2.31e-05	0.00151	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.26e-05	0.00148	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GGCT—gestational diabetes	2.26e-05	0.00147	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MTNR1B—gestational diabetes	2.06e-05	0.00134	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RBP4—gestational diabetes	2.01e-05	0.00131	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GLS2—gestational diabetes	1.97e-05	0.00129	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NAMPT—gestational diabetes	1.96e-05	0.00128	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GCK—gestational diabetes	1.95e-05	0.00127	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MTNR1B—gestational diabetes	1.87e-05	0.00122	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LEP—gestational diabetes	1.86e-05	0.00122	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RBP4—gestational diabetes	1.83e-05	0.00119	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.76e-05	0.00115	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GGCT—gestational diabetes	1.74e-05	0.00114	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	1.71e-05	0.00112	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NAMPT—gestational diabetes	1.55e-05	0.00101	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GCK—gestational diabetes	1.54e-05	0.001	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GLS2—gestational diabetes	1.52e-05	0.000994	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LEP—gestational diabetes	1.43e-05	0.000934	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP19A1—gestational diabetes	1.42e-05	0.000929	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—FGF2—gestational diabetes	1.42e-05	0.000925	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.39e-05	0.000906	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GCK—gestational diabetes	1.38e-05	0.0009	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NAMPT—gestational diabetes	1.35e-05	0.000884	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GCK—gestational diabetes	1.35e-05	0.000879	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEP—gestational diabetes	1.31e-05	0.000853	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NAMPT—gestational diabetes	1.28e-05	0.000833	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GCK—gestational diabetes	1.27e-05	0.000828	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP19A1—gestational diabetes	1.12e-05	0.000733	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—FGF2—gestational diabetes	1.09e-05	0.000709	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NAMPT—gestational diabetes	1.08e-05	0.000706	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GCK—gestational diabetes	1.07e-05	0.000701	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—gestational diabetes	1.05e-05	0.000688	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP19A1—gestational diabetes	1.01e-05	0.000658	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—FGF2—gestational diabetes	9.92e-06	0.000648	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP19A1—gestational diabetes	9.84e-06	0.000642	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP19A1—gestational diabetes	9.27e-06	0.000605	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—gestational diabetes	9.15e-06	0.000597	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NAMPT—gestational diabetes	8.34e-06	0.000545	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—gestational diabetes	8.32e-06	0.000543	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCK—gestational diabetes	8.29e-06	0.000541	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGF2—gestational diabetes	8e-06	0.000522	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP19A1—gestational diabetes	7.85e-06	0.000513	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF2—gestational diabetes	6.95e-06	0.000454	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF2—gestational diabetes	6.32e-06	0.000413	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP19A1—gestational diabetes	6.06e-06	0.000396	CbGpPWpGaD
